Updates Register with us to receive free information and regular updates
IBD Watch IBD Watch provides practicing physicians with the latest updates on therapeutic trends related to the management of ulcerative colitis and Crohn's disease. Get connected to this month's issue of IBD Watch.
IBD News
8.21.2008 Foundation for Clinical Research in Inflammatory Bowel Disease Announces Fall Advances in IBD Series Read more.
4.22.2008 Cimzia® Approved in the US for the Treatment of Moderate to Severe Crohn's Disease Read more.
4.17.2008 Shire USA Announces Education Program for UC Patients Read more.
1.14.2008 FDA Approves TYSABRI® for the Treatment of Moderate-to-Severe Crohn's Disease Read more.
To learn more about what’s new in inflammatory bowel disease clinical research, visit Clinical Trials.
This site has been underwritten thanks to unrestricted educational grants
from Abbott Laboratories, Procter & Gamble Pharmaceuticals,
Salix Pharmaceuticals, Inc., and Shire USA Pharmaceuticals Inc.